Company news
Vitasora Health Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Cleansing Prospectus
October 19, 2020
Entech Electronics appointed as Global Manufacturing Partner
September 21, 2020
Positive wheezo clinical study results
August 31, 2020
Product Referral Agreement executed with Aust Patients Assoc
August 19, 2020
CY21 Revenue Guidance
July 26, 2020
Respiri signs with BNPL provider ZIP - update
July 20, 2020
Respiri signs with BNPL provider ZIP
July 19, 2020
Exclusive International Sales Agreement with Cipla
July 16, 2020
Agreement with UK Data Research Centre executed
June 25, 2020
Settlement with former CEO
June 18, 2020
Service Agreement with Pharmacy Guild of Australia
June 16, 2020
CEOs Address to Shareholders
May 26, 2020
Security Purchase Plan - Completed
May 5, 2020
Joint Development Agreement signed with Phenix Health
April 14, 2020
Placement completed
March 26, 2020
Placement - investor presentation
March 16, 2020
First batch of wheezos delivered
March 5, 2020
FDA update
January 30, 2020
FDA submission to be lodged
January 29, 2020
Cancellation of shares and options
December 19, 2019
SaaS model & First 500 devices
December 12, 2019
CE Mark, manufacturer & clinical study agreement
December 9, 2019
Chairmans Address to Shareholders
November 25, 2019
Director and CEO Appointment
November 24, 2019
Change of Chairman
November 14, 2019
Update regarding departure of CEO
October 29, 2019
CEO leaving
October 9, 2019
Medical trial in India update
September 20, 2019
Placement of ordinary shares
July 29, 2019
Suspension from Official Quotation
July 28, 2019
India Joint Venture Agreement
May 2, 2019
Appendix 4D and Interim Financial Report - December 2018
February 26, 2019
Completion Of Share Purchase Plan Offer
February 4, 2019
Respiris Share Purchase Plan
January 6, 2019
$3.2M Share Placement
December 18, 2018
Trading halt
December 13, 2018
Appendix 4C and R&D Incentive Announcement
October 29, 2018
Respiri appoints manufacturing partner
September 6, 2018
Appendix 4E and Audited FY2018 Financial Report
August 31, 2018
CEO Operational Review
July 30, 2018
Significant Milestone Progress
May 30, 2018
Respiri Limited - Functional Prototype Completed
April 19, 2018
Respiri limited $3.0m share placement
April 10, 2018
Appendix 4D and Interim Financial Report - December 2017
February 26, 2018
CEO Update and Reaffirmation of 2018 Plans and Milestones
January 29, 2018
Respiri Appoints New Chief Executive Officer
October 15, 2017
Response to ASX Price Query
October 10, 2017
Breath Sensor Partnership with Grey Innovation Commenced
September 12, 2017
Appendix 4E & Annual Financial Report (30 June 2017)
August 30, 2017
Commencing the last step to commercialisation
July 27, 2017
Decks
The 5 newest of 15 decks. Every deck is listed under its year.
- Corporate Update (October 2026)
Corporate update · 21 slides · Oct 6, 2026
- Investor Presentation (June 2026)
Investor deck · 27 slides · Jun 11, 2026
- Investor Presentation (March 2026)
Investor deck · 16 slides · Mar 19, 2026
- Investor Presentation (July 2025)
Investor deck · 31 slides · Jul 2, 2025
- Investor Presentation (June 2025)
Investor deck · 20 slides · Jun 2, 2025